Travere Therapeutics TVTX
NASDAQ TVTX
$56.85 -2.03 (-3.45%)
At close: Oct 1, 2026 · 4:00 PM EDT

Travere Therapeutics (TVTX) Shares Outstanding (Entity) (2011 - 2026)

Updated

Travere Therapeutics' Shares Outstanding (Entity) came in at 94.17 million for Q2 2026, up 5.7% from 89.1 million a year earlier and up 1.9% from the prior quarter.

Analysis

Travere Therapeutics (TVTX) Shares Outstanding (Entity) (2011 - 2026) Analysis & Trends

For FY2025, Travere Therapeutics' Shares Outstanding (Entity) was 90.92 million, up 4.0% from FY2024.

  • Shares Outstanding (Entity) has increased in each of the last six years, with a five-year compound annual growth rate of 11.7% (FY2020 to FY2025).
  • Going back by year, Shares Outstanding (Entity) was 87.45 million in FY2024 (+16.0%), 75.37 million in FY2023 (+17.2%), 64.29 million in FY2022 (+2.9%) and 62.49 million in FY2021 (+19.6%).
  • The Q2 2026 figure represents the highest quarterly Shares Outstanding (Entity) in data going back to Q4 2011.
  • Year-over-year, Shares Outstanding (Entity) has increased for 26 consecutive quarters, with growth averaging 10.2% over the last eight quarters.
  • Across the past five years, year-over-year growth in Shares Outstanding (Entity) ran from 2.0% in Q2 2024 to 19.6% in Q4 2021.
  • Business Quant data shows TVTX's Shares Outstanding (Entity) at 92.4 million (Q1 2026), 90.92 million (Q4 2025) and 89.46 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 Travere Therapeutics 5.55 Bn 5.14 Bn 167.41 Mn 94.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 94.17 Mn
Mar 31, 2026 92.40 Mn
Dec 31, 2025 90.92 Mn
Sep 30, 2025 89.46 Mn
Jun 30, 2025 89.10 Mn
Mar 31, 2025 88.79 Mn
Dec 31, 2024 87.45 Mn
Sep 30, 2024 77.91 Mn
Jun 30, 2024 76.46 Mn
Mar 31, 2024 76.11 Mn
Dec 31, 2023 75.37 Mn
Sep 30, 2023 75.11 Mn
Jun 30, 2023 74.97 Mn
Mar 31, 2023 74.59 Mn
Dec 31, 2022 64.29 Mn
Sep 30, 2022 64.15 Mn
Jun 30, 2022 63.84 Mn
Mar 31, 2022 63.51 Mn
Dec 31, 2021 62.49 Mn
Sep 30, 2021 61.02 Mn
API Access

Travere Therapeutics Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=TVTX&period=max&api_key=YOUR_API_KEY